Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma

Jia Wang, Jie Zuo, Mao‐De Wang, Wan‐Fu Xie, Xiao‐Bin Bai, Xu‐Dong Ma

Open source

DOI
10.1111/cns.13227
Published
2019-10-02
Container
CNS Neuroscience & Therapeutics
Publisher
Wiley
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/cns.13227,
  title = {Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma},
  author = {Jia Wang and Jie Zuo and Mao‐De Wang and Wan‐Fu Xie and Xiao‐Bin Bai and Xu‐Dong Ma},
  year = {2019},
  journal = {CNS Neuroscience \& Therapeutics},
  doi = {10.1111/cns.13227},
  url = {https://doi.org/10.1111/cns.13227}
}

RIS

TY  - JOUR
TI  - Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma
AU  - Jia Wang
AU  - Jie Zuo
AU  - Mao‐De Wang
AU  - Wan‐Fu Xie
AU  - Xiao‐Bin Bai
AU  - Xu‐Dong Ma
PY  - 2019
JO  - CNS Neuroscience & Therapeutics
DO  - 10.1111/cns.13227
UR  - https://doi.org/10.1111/cns.13227
ER  - 

APA

Wang, J., Zuo, J., Wang, M., Xie, W., Bai, X., & Ma, X. (2019). Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.13227

Source records